Defunct Company
Total Trials
2
As Lead Sponsor
1
As Collaborator
Total Enrollment
53
NCT01671956
Evaluation of Safety, Efficacy, Pharmacokinetic and Pharmacodynamic of Bertilimumab in Patients With Active Moderate to Severe Ulcerative Colitis
Phase: Phase 2
Role: Lead Sponsor
Start: Jul 31, 2015
Completion: Mar 31, 2019
NCT02226146
Evaluation of Safety, Efficacy and Pharmacodynamic Effect of Bertilimumab in Patients With Bullous Pemphigoid
Role: Collaborator
Start: Feb 29, 2016
Completion: Apr 30, 2018